Cite Filings / STOK
Feed Companies Filings Check
Sign in

CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company

Stoke Therapeutics, Inc.

Sign in to watch
Ticker
STOK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
471144582
Phone
781-430-8200
Business address
45 WIGGINS AVENUE, BEDFORD, MA, 01730
Former names
ASOthera Pharmaceuticals, Inc.
Filings Insiders Search text
All 632 Financials 117 Shareholder Meetings 10 Executive Compensation 101 Insider Trading 305 Beneficial Ownership Interest 80 Business Combinations 90 Public Offerings 33 Mutual Funds and ETFs 8 Others 91
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-04-22
  3. DEF 14A Proxy Proxy Statement 2025-04-22
  4. DEF 14A Proxy Proxy Statement 2024-04-23
  5. DEF 14A Proxy Proxy Statement 2023-09-28
  6. PRE 14A Proxy Proxy Statement (Preliminary) 2023-09-18
  7. DEF 14A Proxy Proxy Statement 2023-04-27
  8. PRE 14A Proxy Proxy Statement (Preliminary) 2023-04-17
  9. DEF 14A Proxy Proxy Statement 2022-04-26
  10. DEF 14A Proxy Proxy Statement 2021-04-26
  11. DEF 14A Proxy Proxy Statement 2020-04-21

Page 1 of 1 · 10 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…